Related Experiment Videos

[Indomethacin in IRDS with PDA phenomenon (author's transl)]

Klinische Padiatrie
|September 1, 1979
PubMed

Insights

Indomethacin treatment for premature infants with an open ductus arteriosus showed varied results, with some infants experiencing duct closure or improved hemodynamics, while others showed no change or worsened clinical status.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Pharmacology

Context:

  • Premature infants often develop an open ductus arteriosus, a complication requiring intervention.
  • Idiopathic respiratory distress syndrome and apneic spells are common in premature neonates.
  • Artificial ventilation is frequently necessary for premature infants with respiratory compromise.

Purpose:

  • To evaluate the efficacy of indomethacin in treating open ductus arteriosus in premature neonates.
  • To assess the clinical and hemodynamic outcomes following indomethacin administration.
  • To explore reasons for discrepancies in treatment responses.

Summary:

  • Sixteen premature infants requiring ventilation received indomethacin for open ductus arteriosus.
  • Four infants achieved duct closure, and three showed hemodynamic improvement within 24 hours.
  • Eight infants had no change in ductus-dependent symptoms, and one required surgical closure.

Impact:

  • Indomethacin efficacy in this population is variable, necessitating further investigation.
  • Understanding treatment variability is crucial for optimizing neonatal care.
  • Results highlight the need for individualized treatment strategies for premature infants with open ductus arteriosus.

Related Concept Videos